|
5/31/98 Version
ALCOHOL BIBLIOGRAPHY ADDICTION PSYCHIATRY FELLOWSHIP BOSTON UNIVERSITY SCHOOL OF MEDICINE
I. NEUROBIOLOGY Hoffman P.L., Tabakoff B. Alcohol dependence: A commentary on mechanisms. Alcohol & Alcoholism. 31:333-40, 1996.
Tsai S., Gastfriend D. R., Coyle J.T. The glutamatergic basis of human alcoholism. Am J Psychiatry. 152:332-40, 1995.
II. CONCEPTUAL PARADIGMS Jellinek EM. The Disease Concept of Alcoholism. New Haven: Hillhouse Press, 1960.
Zinberg N. Alcohol addiction: toward a more comprehensive definition. In Bean M., Zinberg N. (eds.) Dynamic Approaches to the Understanding and Treatment of Alcoholism. New York: The Free Press, 1981.
Vaillant S. Paths into abstinence (chapter 4) in The Natural History of Alcoholism. Cambridge: The Harvard University Press, 1983.
Barbor T.F., et al Types of alcoholics, I, Evidence for an empirically derived tyopology based on indicators of vulnerability and severity. Arch Sen Psychiatry 49:599-608, 1992.
Jessor R. Perceived opportunity, alienation and drinking behavior. J Pers Soc Psychol 15:215-222, 1970.
Tarter RE., Alternan A.L., Edwards K.L. Vulnerability to alcoholism in men: A behavioral-genetic perspective. J Stud Alcohol 46:329-356, 1985.
III. DIAGNOSTIC/SCREENING EXAMINATIONS
DSM-IV American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., Washington, American Psychiatric Association, 1994.
CAGE Ewing J.E. Detecting alcoholism. The CAGE questionnaire. JAMA 252:1905-1907, 1984.
CARBOHYDRATE-DEFICIENT TRANSFERRIN Schmidt L.G., Schmidt K., Dufeu P., et al Superiority of carbohydrate-deficient transferrin to gamnma-glutamyl-transferase in detecting relapse in alcoholism. Am J Psychiatry 154:75-80, 1997.
Conigrave K.M., Saunders J.B., Whitfield J.B. Diagnostic tests for alcohol consumption. Alcohol & Alcoholism 30 (1) :13-26, 1995.
MAST American Psychiatric Association, Michigan Alcoholism Screening Test (MAST) . An J Psychiatry 127:1665, 1971.
IV. FETAL ALCOHOL SYNDROME
V. INTOXICATION Victor, H., Adams RD. The effect of alcohol on the nervous system. Res Nerv Mental Dis 32:526-533, 1953.
Naranjo CA., Bremner K.E. Behavioral correlates of alcohol intoxication. Addiction. 88:31-41, 1993.
Frezza H., DiPadova C., Pozzato S., et al High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322:95-99, 1990.
MILD ORGANIC BRAIN SYNDROME Scientific American, April, 1985, pg 76.
VI. MEDICAL COMPLICATIONS OF ALCOHOL CONSUMPTION Arnon F., Degtli S., Bern M.A. Molecular biological aspects of alcohol-induced liver disease. Alcoholism: Clinical and Experimental Research. 19:247-256, 1995.
Lieber C.S. Medical disorders of alcoholism. N Engi J Med. 333:1058-65, 1995.
Charness M.E. Brain lesions in alcoholics. Alcoholism. Clinical and Experimental Research. 17:2-11, 1993.
Freedland E.S., McMicken D.B. Alcohol-related seizures, Part II: Clinical presentation and management. J Emergency Medicine. 11:605-18, 1993.
Lewis D.D., Woods SE. Fetal alcohol syndrome. Am Family Physician. 50:1025-32, 1994.
Smith J.W. Medical manifestations of alcoholism in the elderly. Int J Addictions. 30:1749-98, 1995.
VII. COMORBIDITY Regier D.A., Farmer. ME., Rae D.S., et al Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 254:2511-2518, 1990.
Kessler. R.C., Crum R.M., Warner L.A et al Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorhidity Survey. Arch Gem Psychiatry 54:313-321, 1997.
VIII. GENETIC ASPECTS OF ALCOHOL DEPENDENCE Goodwin D.W., Scheilsinger F., Holler N., Hermansen L., Winokur G., Guze 5.5. Drinking problems in adopted and non-adopted sons of alcoholics. Arch Gem Psychiatry 31:164-169m 1974.
Frances R.J. ,Timm S., Bucky S. Studies of familial and non-familial alcoholism. Arch Gem Psychiatry 37:564-566, 1980.
Cloninger C.R. et al Inheritance of alcohol abuse. Arch Gem Psychiatry 38:861-868, 1981.
Begleiter H., Reich T., Hesselbrock V., Porjesz B., Li T.K., Schuckit, M.A., Edenberg H.J., Rice J.P. The collaborative study on genetics of alcoholism. Alcohol Health & Research World. 19:228-236, 1995.
Gelenter J. Genetic factors in alcoholism:evidence and implications. In Kranzler H. (ed.) The Pharmacology of Alcohol Abuse, New York: Springer-verlag 207-313, 1995.
Cloninger C.R. Neurogenic adaptive mechanisms in alcoholism. Science 236:410-416, 1987.
Buydens-Branchey L., Branchey M., Noumair 0., Lieber C. Age of alcoholism onset, I & II. Arch Gem Psychiatry 46:225-236, 1989.
Schuckit, MA. Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151:184-189, 1994.
IX. PHARMACOTHERAPY OF ALCOHOL DEPENDENCE
1. DETOXIFICATION Ciraulo, D.A., Shader, R.I., Ciraulo, A.M., Greenblatt D.J., von Moltke L.L. The treatment of alcohol withdrawal. In Shader RI. (ed.) Manual of Psychiatric Therapeutics, Boston, Little, Brown & Co., 1994.
Mayo-Smith M.F., for American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Pharmacological Management of Alcohol Withdrawal. JAMA 278:144-151, 1997.
Sullivan J.T., Sykora K., Schneiderman J., et al Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar) British J Addiction 84:1353-1357, 1989.
Saitz, R. Mayo-smith M.F., Roberts, M.S., et al Individualized treatment of alcohol withdrawal. JAMA 272:519-523, 1994.
2. AVERSIVE AGENTS / DISUIJFIRAM Fuller R.K., Branchey L., Brightwell DR., et al DisuLfiram treatment of alcoholism: JAMA 256:1449-1489, 1986.
Banys P. The clinical use of disulfiram (antabuse) : A review. J Psychoactive Drugs 20(3) :243-261, 1988.
Brewer C. Recent developments in disulfiram treatment. Alcohol & Alcoholism 28:383-395, 1993.
Wright C., Vafier J.A., Lake C.R. Disulfiram-induced fulminating hepatitis: Guidelines for liver-panel monitoring. J Chin Psychiatry 49:430-434, 1988.
Wicht F. et al Divergence of ethanol and acetaldehyde kinetics and of the disulfiran-alcohol reaction with subjects with and without alcoholic liver disease. Alcoholism: Clinical and Experimental Research 19:356-361, 1995.or 6
3. ANTICRAVING AGENTS:
A. NALTREXONE Volpicelli JR., Alterman A.I., Hayashida H., O’Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gem psychiatry 49:876-880, 1992.
O’Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer RE., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gem Psychiatry 49:894-898, 1992.
Croop R.S., Faulkner E.B., Labriola D.E. The safety of naltrexone in the treatment of alcoholism: results from a multicenter usage study. Arch Gem Psychiatry 54:1130-1135, 1997.
B. ACAMPROSATE Sass H. · et al Relapse prevention by acamprosate. Arch Gem Psychiatry 53:673-680, 1996.
C. SSRI’s Kranzler H.R. Placebo-controlled trial of fluoxetine as a adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995.
4. USE OF BENZODIAZEPINES Ciraulo D.A., Sands B., Shader R. Clinical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 145:1501-1506, 1988.
X. SPECIAL POPULATIONS
WOMEN
GAYS
ELDERLY Council on Scientific Affairs, American Medical Association. Alcoholism in the elderly. JAMA 275:797-XXX 1996.
AMERICAN INDIANS May P.A. The epidemiology of alcohol abuse among American Indians: The mythical and real properties. American Indian Culture and Research J 18(2):121-143, 1994.
XI. PSYCHOSOCIAL AND OTHER TREATMENTS FOR ALCOHOLISM PROJECT MATCH Project Match Research Group Matching alcoholism treatments to client hetergeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 58:7-29, 1997.
1. ALCOHOLICS ANONYMOUS Brown S.D. Therapeutic processes in Alcoholics Anonymous, In McCrady B.S., Miller W.R. (eds.) Research on Alcoholics Anonymous, Opportunities and Alternatives, New Brunswick: Rutgers Center of Alcohol Studies 137-152, 1993.
2. COGNITIVE BEHAVIORAL THERAPY Sandberg, S.S., Marlatt, G.A. Relapse Prevention, In Ciraulo, D.A., Shader, R. (eds.) Clinical Manual of Chemical Dependence. Washington: American Psychiatric Press,Inc., 1991.
4. MOTIVATIONAL ENHANCEMENT THERAPY Miller W.R., Roilnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: The Guilford Press, 1992.
5. BRIEF INTERVENTIONS " FRAMES" Bien T. H., Miller W.R., Tonigan J.S. Brief interventions for alcohol problems: a review. Addiction 88:315-335, 1993.
6. 28 DAY REHABILITATION PROGRAMS Walsh D.C. et al A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med 325:775-782, 1991.
7. BRIEF PSYCHOTHERAPY
8. COUNTERTRANSFERENCE ISSUES Shaffer H.J. Denial, Ambivalence & Countertransference Hate, In Levin J.D., Weiss, a. (eds.) Alcoholism: Dynamics and Treatment Northdale, New Jersey: Jason Aronson, Inc., 1993.
John A. Renner, Jr., M.D. I. NeurobiologyHoffman, PL, Tabakoff, B. Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol 1996; 31:333-40.Tsai, G, Gastfriend, DR, Coyle, JT. The glutamatergic basis of human alcoholism [see comments]. Am J Psychiatry 1995; 152:332-40. II. Conceptual Paradigms III. Diagnostic/Screening Examinations IV. Fetal Alcohol Syndrome V. Intoxication VI. Medical Complications of Alcohol ConsumptionArnon, R, Esposti, SD, Zern, MA. Molecular biological aspects of alcohol-induced liver disease. Alcohol Clin Exp Res 1995; 19:247-56. Charness, ME. Brain lesions in alcoholics. Alcohol Clin Exp Res 1993; 17:2-11. Freedland, ES, McMicken, DB. Alcohol-related seizures, Part II: Clinical presentation and management. J Emerg Med 1993; 11:605-18. Lewis, DD, Woods, SE. Fetal alcohol syndrome. Am Fam Physician 1994; 50:1025-32, 1035-6. Lieber, CS. Medical disorders of alcoholism [see comments]. N Engl J Med 1995; 333:1058-65. Smith, JW. Medical manifestations of alcoholism in the elderly. Int J Addict 1995; 30:1749-98. VI. Comorbidity VIII. Genetic Aspects of Alcohol Dependence IX. Pharmacotherapy of Alcohol Dependence X. Special Populations Xi. Psychosocial and other treatments for alcoholism
|